SynthesisDermatologic therapy2022

Dupilumab therapy in atopic dermatitis is safe during COVID-19 infection era: A systematic review and meta-analysis of 1611 patients.

Amr Ehab El-Qushayri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.